Cargando…
Should we avoid protease inhibitors in first lines due to their lipid side effects? - cons
Autor principal: | Stellbrink, Hans-Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221059/ http://dx.doi.org/10.1186/1471-2334-14-S2-S12 |
Ejemplares similares
-
First Line Therapy in 2014
por: Nelson, Mark
Publicado: (2014) -
Is ART suspension never a good idea? - Cons
por: Poli, Guido
Publicado: (2014) -
Thalassemias: can we reduce the national burden?
por: Colah, Roshan
Publicado: (2014) -
Uniparental disomy - clinical consequences due to imprinting and activation of recessive genes
por: Liehr, Thomas
Publicado: (2014) -
Non-invasive prenatal diagnosis using massively parallel sequencing - first experience in Germany
por: Wegner, Rolf-Dieter, et al.
Publicado: (2014)